# BBLN

## Overview
The BBLN gene encodes the bublin coiled-coil protein, a member of the Hero protein family, which is involved in stabilizing aggregation-prone proteins. This protein is characterized by a coiled-coil domain flanked by intrinsically disordered regions, facilitating its role in protein-protein interactions. Bublin coiled-coil protein is primarily associated with the organization of intermediate filaments, particularly in epithelial cells, where it interacts with keratin proteins such as KRT8 and KRT18. Additionally, it engages with components of the V-ATPase complex, implicating it in cellular processes like pH regulation and vesicular trafficking. In cardiac research, BBLN is noted for its interaction with calcium/calmodulin-dependent protein kinase II delta (CAMK2D), suggesting a role in calcium signaling pathways and cardiac pathology. The gene's expression is upregulated in certain cardiac conditions, such as tetralogy of Fallot, linking it to adverse cardiac remodeling and dysfunction (Abd2023BBLN; Remmelzwaal2021BBLN1).

## Structure
The human gene BBLN, also known as bublin coiled-coil protein, encodes a protein characterized by a coiled-coil domain flanked by intrinsically disordered regions. This structural motif is involved in protein-protein interactions and is similar to the C. elegans gene BBLN-1, suggesting evolutionary conservation (Remmelzwaal2021BBLN1). The BBLN protein is 83 amino acids long and is predicted to have a central coiled-coil domain, which is a common feature in proteins that mediate structural and functional interactions (Remmelzwaal2021BBLN1).

The BBLN protein interacts with intermediate filaments, specifically keratin 8 (KRT8) and keratin 18 (KRT18), in human cells, indicating its role in maintaining intermediate filament organization (Remmelzwaal2021BBLN1). Mass spectrometry analysis has identified V-ATPase subunit D (ATP6V1D) and subunit F (ATP6V1F) as interaction partners, which are orthologs of high-confidence BBLN-1 interactors in C. elegans, further supporting its functional conservation (Remmelzwaal2021BBLN1).

The protein is associated with the Hero protein family, which is known for stabilizing aggregation-prone proteins, suggesting a potential role in anti-aggregation activity toward mammalian intermediate filaments (Sundaram2021Intermediate). However, specific details on post-translational modifications, splice variant isoforms, or the quaternary structure of BBLN are not provided in the available context.

## Function
The BBLN gene, also known as bublin coiled coil protein, plays a significant role in the organization of intermediate filaments (IFs) and the maintenance of apical membrane morphology in epithelial cells. In mammals, BBLN interacts with keratin 8 (KRT8) and keratin 18 (KRT18), which are components of the apical IF network in simple epithelia, such as enterocytes. This interaction suggests that BBLN is involved in the structural organization of the cytoskeleton, particularly in epithelial cells, where it is enriched in apical and perinuclear regions (Remmelzwaal2021BBLN1).

BBLN also interacts with components of the V-ATPase complex, specifically subunits D (ATP6V1D) and F (ATP6V1F), which are involved in cellular processes such as pH regulation and vesicular trafficking. These interactions highlight BBLN's role in cellular organization and function, particularly in maintaining the structural integrity of epithelial cells (Remmelzwaal2021BBLN1).

In the context of cardiac function, BBLN is implicated in the activation of CAMK2D, a kinase involved in various cellular processes. This interaction suggests a role for BBLN in calcium signaling pathways, although its specific functions in healthy human cells remain to be fully elucidated (Abd2023BBLN).

## Clinical Significance
The BBLN gene is implicated in several cardiac conditions, particularly those involving cardiac pressure overload and hypoxia. In humans, BBLN is upregulated in heart specimens from patients with tetralogy of Fallot (TOF) with cyanosis, a condition characterized by low oxygen levels, which may trigger this upregulation (Abd2023BBLN). This gene is EGR1-responsive, and EGR1 is induced in cyanotic TOF patient hearts, suggesting a link between hypoxia and BBLN expression (Abd2023BBLN). Elevated BBLN levels correlate with markers of adverse cardiac remodeling and dysfunction in TOF patients, indicating its role as a pathological factor in these conditions (Abd2023BBLN).

In transgenic mice, overexpression of BBLN leads to cardiac hypertrophy and heart failure, mimicking features observed in TOF patients. This is associated with increased CAMK2D activity, which BBLN enhances, leading to cardiac dysfunction (Abd2023BBLN). BBLN also promotes necroptosis, a form of programmed cell death, contributing to cardiac degeneration (Abd2023BBLN). These findings suggest that BBLN plays a significant role in cardiac pathologies, particularly under conditions of pressure overload and hypoxia, and may be a potential target for therapeutic intervention in hypoxic heart diseases (Abd2023BBLN).

## Interactions
BBLN, also known as bublin coiled-coil protein, is involved in several protein-protein interactions that are crucial for its function in cellular processes. In mammalian cells, BBLN interacts with intermediate filament proteins such as keratin 8 (KRT8), keratin 18 (KRT18), and keratin 20 (KRT20), as demonstrated in HEK293T cells through affinity purification and pull-down analysis (Remmelzwaal2021BBLN1). These interactions suggest a conserved role in intermediate filament organization, similar to its ortholog BBLN-1 in C. elegans.

BBLN also interacts with subunits of the V-ATPase complex, specifically subunit D (ATP6V1D) and subunit F (ATP6V1F), which are orthologs of C. elegans VHA-14 and VHA-9, respectively (Remmelzwaal2021BBLN1). This indicates a potential role in cellular processes involving V-ATPase.

In cardiac research, BBLN has been identified as an interacting partner of calcium/calmodulin-dependent protein kinase II delta (CAMK2D). BBLN enhances CAMK2D activity by promoting its autophosphorylation on T287, which is associated with cardiac dysfunction and remodeling (Abd2023BBLN). This interaction is dependent on the presence of Ca2+/calmodulin and is crucial for BBLN's role in cardiac pathology (Abd2023BBLN).


## References


[1. (Abd2023BBLN) Joshua Abd Alla, Andreas Langer, Stefan Wolf, Xuebin Fu, Mohamed Abdelfattah Rageh, and Ursula Quitterer. Bbln triggers camk2d pathology in mice under cardiac pressure overload and potentially in unrepaired hearts with tetralogy of fallot. Nature Cardiovascular Research, 2(11):1044–1059, October 2023. URL: http://dx.doi.org/10.1038/s44161-023-00351-6, doi:10.1038/s44161-023-00351-6. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s44161-023-00351-6)

[2. (Sundaram2021Intermediate) Meera V. Sundaram. Intermediate filaments: new insights are bublin up. Current Biology, 31(11):R719–R721, June 2021. URL: http://dx.doi.org/10.1016/j.cub.2021.04.031, doi:10.1016/j.cub.2021.04.031. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cub.2021.04.031)

[3. (Remmelzwaal2021BBLN1) Sanne Remmelzwaal, Florian Geisler, Riccardo Stucchi, Suzanne van der Horst, Milena Pasolli, Jason R. Kroll, Olga D. Jarosinska, Anna Akhmanova, Christine A. Richardson, Maarten Altelaar, Rudolf E. Leube, João J. Ramalho, and Mike Boxem. Bbln-1 is essential for intermediate filament organization and apical membrane morphology. Current Biology, 31(11):2334-2346.e9, June 2021. URL: http://dx.doi.org/10.1016/j.cub.2021.03.069, doi:10.1016/j.cub.2021.03.069. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cub.2021.03.069)